Literature DB >> 1671273

Pharmacokinetics of inhaled recombinant and natural alpha interferon.

P Maasilta, M Halme, K Mattson, K Cantell.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1671273     DOI： 10.1016/0140-6736(91)91009-j

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Systemic absorption and activity of recombinant consensus interferons after intratracheal instillation and aerosol administration.

Authors:  R W Niven; K L Whitcomb; M Woodward; J Liu; C Jornacion
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

Review 2.  Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines.

Authors:  Yinan Xiao; Hanyue Xu; Wen Guo; Yunuo Zhao; Yuling Luo; Ming Wang; Zhiyao He; Zhenyu Ding; Jiyan Liu; Lei Deng; Fushen Sha; Xuelei Ma
Journal:  Mol Biomed       Date:  2020-12-03

Review 3.  Inhaled therapeutics for prevention and treatment of pneumonia.

Authors:  Amar Safdar; Samuel A Shelburne; Scott E Evans; Burton F Dickey
Journal:  Expert Opin Drug Saf       Date:  2009-07       Impact factor: 4.250

4.  Quadruple therapy for asymptomatic COVID-19 infection patients.

Authors:  Ling Wang; Xiaopeng Xu; Junshan Ruan; Saijin Lin; Jinhua Jiang; Hong Ye
Journal:  Expert Rev Anti Infect Ther       Date:  2020-05-03       Impact factor: 5.091

Review 5.  Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines.

Authors:  Yinan Xiao; Hanyue Xu; Wen Guo; Yunuo Zhao; Yuling Luo; Ming Wang; Zhiyao He; Zhenyu Ding; Jiyan Liu; Lei Deng; Fushen Sha; Xuelei Ma
Journal:  Mol Biomed       Date:  2020-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.